Cargando…

Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel

Schistosomiasis is one of the most common human parasitic diseases whose socioeconomic impact is only surpassed by malaria. Praziquantel (PZQ) is the only drug commercially available for the treatment of all schistosome species causing disease in humans. However, there has been stronger evidences of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto-Almeida, António, Mendes, Tiago, de Oliveira, Rosimeire Nunes, Corrêa, Sheila de Andrade Penteado, Allegretti, Silmara Marques, Belo, Silvana, Tomás, Ana, Anibal, Fernanda de Freitas, Carrilho, Emanuel, Afonso, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844704/ https://www.ncbi.nlm.nih.gov/pubmed/27199925 http://dx.doi.org/10.3389/fmicb.2016.00594

Ejemplares similares

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)

Anti-Inflammatory Properties of Menthol and Menthone in Schistosoma mansoni Infection
por: Zaia, Mauricio G., et al.
Publicado: (2016)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

Schiff bases complexed with iron and their relation with the life cycle and infection by Schistosoma mansoni
por: da Silva, Juliana Virginio, et al.
Publicado: (2022)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study
por: Mahende, Muhidin K., et al.
Publicado: (2021)

Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

Activation of transient receptor potential channel Sm.(Schistosoma mansoni)TRPM(PZQ) by PZQ, enhanced Ca(++) influx, spastic paralysis, and tegumental disrupture—the deadly cascade in parasitic schistosomes, other trematodes, and cestodes
por: Harder, Achim
Publicado: (2020)

The Anthelmintic Activity of Praziquantel Analogs Correlates with Structure–Activity Relationships at TRPM(PZQ) Orthologs
por: Sprague, Daniel J., et al.
Publicado: (2023)

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
por: Schneeberger, Pierre H. H., et al.
Publicado: (2018)

A single locus determines praziquantel response in Schistosoma mansoni
por: Chevalier, Frédéric D., et al.
Publicado: (2023)

Effects of Immunization with Recombinant Schistosoma mansoni Enzymes AK and HGPRT: Murine Infection Control
por: Fattori, Ana Carolina Maragno, et al.
Publicado: (2023)

Anthelmintic Activity In Vivo of Epiisopiloturine against Juvenile and Adult Worms of Schistosoma mansoni
por: Guimarães, Maria A., et al.
Publicado: (2015)

Praziquantel Treatment Decreases Schistosoma mansoni Genetic Diversity in Experimental Infections
por: Coeli, Regina, et al.
Publicado: (2013)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
por: Abla, Nada, et al.
Publicado: (2017)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Epiisopilosine alkaloid has activity against Schistosoma mansoni in mice without acute toxicity
por: Guimarães, Maria A., et al.
Publicado: (2018)

A Study of the Granulomatous Responses Induced by Different Strains of Schistosoma mansoni
por: Zuim, Nádia Regina Borim, et al.
Publicado: (2012)

Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
por: Melman, Sandra D., et al.
Publicado: (2009)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
por: Amara, Rokaya O, et al.
Publicado: (2018)

Curcumin Generates Oxidative Stress and Induces Apoptosis in Adult Schistosoma mansoni Worms
por: de Paula Aguiar, Daniela, et al.
Publicado: (2016)

Investigating Immunization With Nucleotide Enzymes of Schistosoma mansoni: Nucleoside Diphosphate Kinase and Adenylosuccinate Lyase as New Antigenic Targets Against Schistosomiasis
por: Cagnazzo, Túlio di Orlando, et al.
Publicado: (2020)

Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2019)

Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure
por: McCusker, Paul, et al.
Publicado: (2021)

Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection
por: Nono, Justin Komguep, et al.
Publicado: (2021)

Protein undernutrition reduces the efficacy of praziquantel in a murine model of Schistosoma mansoni infection
por: Kadji Fassi, Joseph Bertin, et al.
Publicado: (2022)

Effect of Maternal Schistosoma mansoni Infection and Praziquantel Treatment During Pregnancy on Schistosoma mansoni Infection and Immune Responsiveness among Offspring at Age Five Years
por: Tweyongyere, Robert, et al.
Publicado: (2013)

In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human Infections
por: Lamberton, Poppy H. L., et al.
Publicado: (2010)

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni
por: Mokbel, Kamal El-Din M., et al.
Publicado: (2020)

The antioxidants resveratrol and N-acetylcysteine enhance anthelmintic activity of praziquantel and artesunate against Schistosoma mansoni
por: Gouveia, Maria João, et al.
Publicado: (2019)

Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda
por: Kabatende, Joseph, et al.
Publicado: (2023)

Phytol, a Diterpene Alcohol from Chlorophyll, as a Drug against Neglected Tropical Disease Schistosomiasis Mansoni
por: de Moraes, Josué, et al.
Publicado: (2014)

Comparison of the in vitro Effects of One-day Exposure to Amodiaquine and Praziquantel on Schistosoma mansoni Adult Worm Pairs
por: Mitsui, Yoshinori
Publicado: (2014)

Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug
por: Mwangi, Ibrahim N., et al.
Publicado: (2014)

Evaluation of the Anti-schistosomal Effects of Turmeric (Curcuma longa) Versus Praziquantel in Schistosoma mansoni Infected Mice
por: HUSSEIN, Atef, et al.
Publicado: (2017)

The effects of subcurative praziquantel treatment on life‐history traits and trade‐offs in drug‐resistant Schistosoma mansoni
por: Viana, Mafalda, et al.
Publicado: (2017)

Complementary Effect of Capparis Spinosa L. and Silymarin With/without Praziquantel on Mice Experimentally Infected with Schistosoma Mansoni
por: El-Hawary, S. S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6id3dkhk6omcgfdvoiecaiefpt